# Beyond Bell’s: A Case Study of Bilateral Facial Paralysis From Lyme Neuroborreliosis

**Authors:** Kainuo Wu, Christopher Peterson, Mariana Gomez de la Espriella, Tasaduq Fazili

PMC · DOI: 10.7759/cureus.100160 · Cureus · 2025-12-26

## TL;DR

A rare case of bilateral facial paralysis caused by Lyme disease is presented, emphasizing the need for thorough diagnosis and early treatment.

## Contribution

This case study highlights the importance of considering Lyme neuroborreliosis in atypical presentations of bilateral facial palsy.

## Key findings

- Bilateral facial palsy can be caused by Lyme neuroborreliosis even without typical exposure history or rash.
- Prompt diagnosis and treatment with intravenous and oral antibiotics led to complete neurological recovery.
- Early specialty consultation is crucial for managing atypical neurological presentations.

## Abstract

Bilateral facial palsy is a rare neurological presentation that often reflects an underlying systemic disease that requires prompt and comprehensive diagnostic evaluation to guide appropriate management.

A 50-year-old man presented with bilateral facial palsy without a recent history of vector exposure or characteristic rash. Extensive diagnostic studies included autoimmune panels, neurovascular and structural imaging, cerebrospinal fluid (CSF) analysis, infectious cultures, and various viral and bacterial serologies. The absence of a clear exposure history and variable latency period following initial exposure contributed to diagnostic uncertainty. Lyme meningitis was confirmed based on CSF findings and a markedly elevated Borrelia CSF to serum antibody index after other etiologies were excluded. The patient was treated with seven days of intravenous ceftriaxone and 14 days of oral doxycycline, achieving complete neurological recovery at three months.

This case highlights the exhaustive workup required to identify the cause of bilateral facial palsy. Early specialty consultation is critical to expedite diagnostic workup. Clinicians should maintain a high index of clinical suspicion for Lyme disease despite an absent exposure history or rash. Prompt recognition of bilateral facial palsy and timely intervention are essential to ensure optimal neurological recovery.

## Linked entities

- **Chemicals:** ceftriaxone (PubChem CID 5479530), doxycycline (PubChem CID 54671203)

## Full-text entities

- **Diseases:** Bilateral facial palsy (MESH:D005158), Bell's (MESH:D020330), Lyme disease (MESH:D008193), Lyme Neuroborreliosis (MESH:D020852), rash (MESH:D005076)
- **Chemicals:** doxycycline (MESH:D004318), ceftriaxone (MESH:D002443)
- **Species:** Homo sapiens (human, species) [taxon 9606], Borrelia (Relapsing Fever Borrelia, genus) [taxon 138]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12833029/full.md

## References

20 references — full list in the complete paper: https://tomesphere.com/paper/PMC12833029/full.md

---
Source: https://tomesphere.com/paper/PMC12833029